天然痘治療法の世界市場:薬物、ワクチン

LINEで送る

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Drugs – Market size and forecast 2018-2023

Vaccines – Market size and forecast 2018-2023

Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 10: TRENDS

Increasing efforts by vendors

Growing threat of bioterrorism

Expedited approvals

PART 11: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 12: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Bavarian Nordic AS

Emergent BioSolutions Inc.

Pfizer Inc.

SIGA Technologies Inc.

PART 13: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 14: EXPLORE TECHNAVIO

Exhibit 01: Vendors: Key offerings

Exhibit 02: Global pharmaceuticals market

Exhibit 03: Segments of global pharmaceuticals market

Exhibit 04: Market characteristics

Exhibit 05: Market characteristics analysis

Exhibit 06: Market segments

Exhibit 07: Market definition – Inclusions and exclusions checklist

Exhibit 08: Market size 2018

Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 11: Five forces analysis 2018

Exhibit 12: Five forces analysis 2023

Exhibit 13: Bargaining power of buyers

Exhibit 14: Bargaining power of suppliers

Exhibit 15: Threat of new entrants

Exhibit 16: Threat of substitutes

Exhibit 17: Threat of rivalry

Exhibit 18: Market condition – Five forces 2018

Exhibit 19: Product – Market share 2018-2023 (%)

Exhibit 20: Comparison by product

Exhibit 21: Drugs – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Drugs – Year-over-year growth 2019-2023 (%)

Exhibit 23: Vaccines – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Vaccines – Year-over-year growth 2019-2023 (%)

Exhibit 25: Market opportunity by product

Exhibit 26: Customer landscape

Exhibit 27: Customer landscape analysis

Exhibit 28: Market share by geography 2018-2023 (%)

Exhibit 29: Geographic comparison

Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: North America – Year-over-year growth 2019-2023 (%)

Exhibit 32: Top 3 countries in North America

Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 35: Top 3 countries in Europe

Exhibit 36: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 37: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 38: Top 3 countries in Asia

Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 41: Top 3 countries in ROW

Exhibit 42: Key leading countries

Exhibit 43: Market opportunity

Exhibit 44: Decision framework

Exhibit 45: Impact of drivers and challenges

Exhibit 46: Vendor landscape

Exhibit 47: Landscape disruption

Exhibit 48: Vendor landscape analysis

Exhibit 49: Vendors covered

Exhibit 50: Vendor classification

Exhibit 51: Market positioning of vendors

Exhibit 52: Bavarian Nordic AS – Vendor overview

Exhibit 53: Bavarian Nordic AS – Business segments

Exhibit 54: Bavarian Nordic AS – Organizational developments

Exhibit 55: Bavarian Nordic AS – Geographic focus

Exhibit 56: Bavarian Nordic AS – Key offerings

Exhibit 57: Emergent BioSolutions Inc. – Vendor overview

Exhibit 58: Emergent BioSolutions Inc. – Business segments

Exhibit 59: Emergent BioSolutions Inc. – Organizational developments

Exhibit 60: Emergent BioSolutions Inc. – Key offerings

Exhibit 61: Pfizer Inc. – Vendor overview

Exhibit 62: Pfizer Inc. – Business segments

Exhibit 63: Pfizer Inc. – Organizational developments

Exhibit 64: Pfizer Inc. – Geographic focus

Exhibit 65: Pfizer Inc. – Segment focus

Exhibit 66: Pfizer Inc. – Key offerings

Exhibit 67: SIGA Technologies Inc. – Vendor overview

Exhibit 68: SIGA Technologies Inc. – Business segments

Exhibit 69: SIGA Technologies Inc. – Organizational developments

Exhibit 70: SIGA Technologies Inc. – Key offerings

Exhibit 71: Validation techniques employed for market sizing

Exhibit 72: List of abbreviations

Exhibit 73: Definition of market positioning of vendors




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様